Recent News

Labs race to make pharmaceutical MDMA available to treat mental illness

The Globe & Mail

April 15, 2023

The Globe & Mail visited the lab operated by our subsidiary Psilo Scientific and interviewed our team regarding MDMA and the Special Access Program.